Alzheimer disease immunotherapeutics: then and now (Q27001031)

Bhumika Bhatt

series ordinal

2

1 reference

Shashikantha Sk

series ordinal

3

1 reference

Jagbir Singh Malik

series ordinal

4

1 reference

language of work or name

1 reference

2014

1 reference

Human Vaccines & Immunotherapeutics

published in

1 reference

volume

10

1 reference

issue

9

1 reference

page(s)

2741-3

1 reference

Immunotherapy for Alzheimer's disease: hoops and hurdles

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4975071

Cholinesterases, a target of pharmacology and toxicology

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4975071

Forecasting the global burden of Alzheimer’s disease

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4975071

Survival and cause of death in Alzheimer's disease and multi-infarct dementia

21 March 2017

1 reference

https://api.crossref.org/works/10.4161/21645515.2014.970959

Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia

22 April 2017

1 reference

https://api.crossref.org/works/10.4161/21645515.2014.970959

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4975071

Advances in the development of vaccines for Alzheimer's disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4975071

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4975071

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4975071

Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4975071

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4975071

2013 Alzheimer's disease facts and figures

28 September 2017

1 reference

https://pubmed.ncbi.nlm.nih.gov/25483498

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/21645515.2014.970959

1 reference

1 reference

PubMed publication ID

25483498

1 reference